| Literature DB >> 29328449 |
Rui Lin1, Yufeng Wang1, Kun Ji1, Zhongyan Liu1, Shuai Xiao1, Dehua Zhou1, Quanning Chen1, Baomin Shi1.
Abstract
Due to the lack of potential organs, hepatocellular transplantation has been considered for treating end-stage liver disease. Induced pluripotent stem cells (iPSCs) are reverted from somatic cells and are able to differentiate into hepatocytes. The present study aimed to investigate the mechanisms underlying iPSC differentiation to hepatocytes. GSE66076 was downloaded from the Gene Expression Omnibus; this database includes data from 3 undifferentiated (T0), 3 definitive endoderm (T5), and 3 early hepatocyte (T24) samples across hepatic‑directed differentiation of iPSCs. Differentially expressed genes (DEGs) between T0 and T5 or T24 samples were identified using the linear models for microarray data package in Bioconductor, and enrichment analyses were performed. Using the weighted correlation network analysis package in R, clusters were identified for the merged DEGs. Cytoscape was used to construct protein‑protein interaction (PPI) networks for DEGs identified to belong to significant clusters. Using the ReactomeFI plugin in Cytoscape, functional interaction (FI) networks were constructed for the common genes. A total of 433 and 1,342 DEGs were identified in the T5 and T24 samples respectively, compared with the T0 samples. Blue and turquoise clusters were identified as significant gene clusters. In the PPI network for DEGs in the blue cluster, the key node fibroblast growth factor 2 (FGF2) could interact with bone morphogenetic protein 2 (BMP2). Cyclin‑dependent kinase 1 (CDK1) was demonstrated to have the highest degree (degree=71) in the PPI network for DEGs in the turquoise cluster. Enrichment analysis for the common genes, including hepatocyte nuclear factor 4α (HNF4A) and epidermal growth factor (EGF), in the FI network indicated that EGF and FGF2 were enriched in the Ras and Rap1 signaling pathways. The present results suggest that FGF2, BMP2, CDK1, HNF4A and EGF may participate in the differentiation of iPSCs into hepatocytes.Entities:
Mesh:
Substances:
Year: 2018 PMID: 29328449 PMCID: PMC5802208 DOI: 10.3892/mmr.2018.8385
Source DB: PubMed Journal: Mol Med Rep ISSN: 1791-2997 Impact factor: 2.952
Top 3 functions and pathways enriched for differentially expressed genes in T5 samples.
| Category | ID | Description | FDR | Gene no. | Gene symbol |
|---|---|---|---|---|---|
| Upregulated | |||||
| GO_BP | GO:0009888 | tissue development | 2.70E-13 | 72 | |
| GO:0072359 | circulatory system development | 2.88E-11 | 46 | ||
| GO:0072358 | cardiovascular system development | 2.88E-11 | 46 | ||
| GO_CC | GO:0005615 | extracellular space | 2.85E-07 | 47 | |
| GO:0002116 | semaphorin receptor complex | 2.12E-04 | 4 | ||
| GO:0009897 | external side of plasma membrane | 5.50E-04 | 15 | ||
| GO_MF | GO:0060089 | molecular transducer activity | 2.50E-04 | 50 | |
| GO:0004871 | signal transducer activity | 2.50E-04 | 50 | ||
| GO:0004872 | receptor activity | 7.51E-04 | 46 | ||
| KEGG pathway | 119526 | other semaphorin interactions | 5.42E-03 | 5 | |
| 576262 | extracellular matrix organization | 1.10E-02 | 15 | ||
| 198832 | adipogenesis | 5.42E-03 | 11 | ||
| Downregulated | GO:0007267 | cell-cell signaling | 1.20E-02 | 28 | |
| GO_BP | GO:0007268 | synaptic transmission | 2.03E-02 | 20 | |
| GO:0045766 | positive regulation of angiogenesis | 4.82E-02 | 7 | ||
| GO_CC | GO:0045202 | synapse | 1.42E-03 | 18 | |
| GO:0097060 | synaptic membrane | 1.42E-03 | 11 | ||
| GO:0045211 | postsynaptic membrane | 1.42E-03 | 10 |
GO, Gene Ontology; KEGG, Kyoto Encyclopedia of Genes and Genomes; BP, biological process; CC, cellular component; MF, molecular function; FDR, false discovery rate.
Top 3 functions and pathways enriched for differentially expressed genes in T24 samples.
| Category | ID | Description | FDR | Gene no. | Gene symbol | |
|---|---|---|---|---|---|---|
| Upregulated | ||||||
| GO_BP | GO:0030198 | extracellular matrix organization | 1.39E-21 | 66 | ||
| GO:0043062 | extracellular structure organization | 1.39E-21 | 66 | |||
| GO:0009611 | response to wounding | 6.97E-19 | 122 | |||
| GO_CC | GO:0005615 | extracellular space | 8.05E-44 | 165 | ||
| GO:0031012 | extracellular matrix | 1.34E-18 | 63 | |||
| GO:0005578 | proteinaceous extracellular matrix | 2.12E-17 | 55 | |||
| GO_MF | GO:0005102 | receptor binding | 1.16E-11 | 113 | ||
| GO:1901681 | sulfur compound binding | 6.03E-09 | 34 | |||
| GO:0050839 | cell adhesion molecule binding | 7.59E-09 | 29 | |||
| KEGG pathway | 83073 | complement and coagulation cascades | 1.27E-16 | 28 | ||
| 198880 | complement and coagulation cascades | 7.64E-15 | 23 | |||
| M4470 | extrinsic prothrombin activation pathway | 7.08E-13 | 12 | |||
| Downregulated | GO:0000278 | mitotic cell cycle | 8.81E-55 | 141 | ||
| GO_BP | GO:0007049 | cell cycle | 1.55E-51 | 180 | ||
| GO:0022402 | cell cycle process | 1.06E-48 | 151 | |||
| GO_CC | GO:0005694 | chromosome | 1.18E-44 | 116 | ||
| GO:0044427 | chromosomal part | 1.44E-36 | 97 | |||
| GO:0032993 | protein-DNA complex | 6.76E-32 | 62 | |||
| GO_MF | GO:0032559 | adenyl ribonucleotide binding | 1.40E-07 | 94 | ||
| GO:0005524 | ATP binding | 1.40E-07 | 92 | |||
| GO:0030554 | adenyl nucleotide binding | 1.52E-07 | 94 | |||
| KEGG | 530733 | cell cycle | 1.67E-49 | 105 | ||
| pathway | 105765 | cell cycle, mitotic | 1.57E-35 | 81 | ||
| 105750 | G2/M checkpoints | 7.54E-21 | 24 |
GO, Gene Ontology; KEGG, Kyoto Encyclopedia of Genes and Genomes; BP, biological process; CC, cellular component; MF, molecular function; FDR, false discovery rate.
Figure 1.Dendrogram for identifying gene clusters for the merged differentially expressed genes using weighted correlation network analysis.
Top 5 functions and pathways enriched for differentially expressed genes in the blue cluster.
| Category | ID | Description | FDR | Gene no. | Gene symbol |
|---|---|---|---|---|---|
| GO_BP | GO:2000026 | regulation of multicellular organismal development | 5.97E-06 | 78 | |
| GO:0001763 | morphogenesis of a branching structure | 1.17E-05 | 24 | ||
| GO:0048589 | developmental growth | 1.17E-05 | 30 | ||
| GO:0061138 | morphogenesis of a branching epithelium | 1.17E-05 | 23 | ||
| GO:0048754 | branching morphogenesis of an epithelial tube | 1.17E-05 | 21 | ||
| GO_CC | GO:0044420 | extracellular matrix component | 1.46E-03 | 15 | |
| GO:0000785 | chromatin | 2.27E-03 | 26 | ||
| GO:0005604 | basement membrane | 2.36E-03 | 12 | ||
| GO:0005694 | chromosome | 3.79E-03 | 40 | ||
| GO:0044427 | chromosomal part | 4.60E-03 | 35 | ||
| KEGG | 106540 | telomere maintenance | 7.80E-04 | 13 | |
| pathway | 366238 | amyloids | 9.81E-04 | 13 | |
| 106548 | packaging of telomere ends | 9.81E-04 | 10 | ||
| 477134 | meiotic synapsis | 9.81E-04 | 12 | ||
| 83122 | systemic lupus erythematosus | 1.00E-03 | 16 |
GO, Gene Ontology; KEGG, Kyoto Encyclopedia of Genes and Genomes; BP, biological process; CC, cellular component; FDR, false discovery rate.
Top 5 functions and pathways enriched for differentially expressed genes in the turquoise cluster.
| Category | ID | Description | FDR | Gene no. | Gene symbol |
|---|---|---|---|---|---|
| GO_BP | GO:0000278 | mitotic cell cycle | 3.93E-28 | 127 | |
| GO:0007067 | mitotic nuclear division | 1.58E-26 | 77 | ||
| GO:0000280 | nuclear division | 1.61E-25 | 90 | ||
| GO:1903047 | mitotic cell cycle process | 8.19E-25 | 111 | ||
| GO:0048285 | organelle fission | 7.14E-24 | 90 | ||
| GO_CC | GO:0005615 | extracellular space | 3.10E-23 | 141 | |
| GO:0000775 | chromosome, centromeric region | 1.99E-16 | 39 | ||
| GO:0005694 | chromosome | 9.93E-16 | 90 | ||
| GO:0000793 | condensed chromosome | 3.71E-15 | 40 | ||
| GO:0000779 | condensed chromosome, centromeric region | 7.92E-15 | 28 | ||
| GO_MF | GO:0005102 | receptor binding | 2.47E-04 | 100 | |
| GO:0030414 | peptidase inhibitor activity | 2.47E-04 | 24 | ||
| GO:0004867 | serine-type endopeptidase inhibitor activity | 2.47E-04 | 17 | ||
| GO:0004866 | endopeptidase inhibitor activity | 2.47E-04 | 23 | ||
| GO:0061135 | endopeptidase regulator activity | 3.74E-04 | 23 | ||
| KEGG | 530733 | cell cycle | 4.76E-16 | 80 | |
| pathway | 105765 | cell cycle, mitotic | 1.16E-14 | 68 | |
| 83073 | complement and coagulation cascades | 1.44E-13 | 26 | ||
| 105815 | mitotic prometaphase | 2.98E-12 | 31 | ||
| 198880 | complement and coagulation cascades | 8.46E-12 | 21 |
GO, Gene Ontology; KEGG, Kyoto Encyclopedia of Genes and Genomes; BP, biological process; CC, cellular component; MF, molecular function; FDR, false discovery rate.
Figure 2.Protein-protein interaction network for differentially expressed genes in the blue cluster.
Figure 3.Protein-protein interaction network for differentially expressed genes in the turquoise cluster.
Figure 4.Venn diagram for identifying the common genes between the two comparison groups: T5 vs. T0 and T24 vs. T0.
Figure 5.FI network for the common genes and the top 11 most significant pathways enriched for genes in the network. (A) FI network for the common genes. The red and green nodes represent up- and downregulated genes, respectively. (B) Top 11 most significant pathways enriched for the genes in the FI network. The y-axis represents the number of genes enriched in each pathway. The x-axis represents the various pathways. Common symbols for the genes involved in each pathway are shown in red. The database sources of the various pathways are included in brackets. FI, functional interaction; C, CellMap; R, Reactome; K, Kyoto Encyclopedia of Genes and Genomes; N, National Cancer Institute Pathway Interaction Database; P, Panther; and B, BioCarta.